Science & Technology



Review: Apple Watch Series 3 is a useful tool for the health-conscious, with diabetes management coming soon

David Lazarus, Los Angeles Times on

Published in Science & Technology News

A senior Medtronic official tells me an Apple Watch app for the company's gear is in the works. He said it could take as long as two years to get it up and running. I suspect it'll be a lot sooner.

One final thought: The FDA doesn't classify the Apple Watch as a medical device, so it's not tax-deductible. That needs to change.

These suckers are pretty awesome, but they're also pricey. The Series 3 starts at $329 for the 38mm model without cellular capability, $399 for cellular-equipped. The slightly larger 42mm version -- which I recommend, having tried both -- costs $30 more.

Their value on the health care front is proven by reports that health-insurance giant Aetna may soon provide free or discounted Apple Watches to its 23 million customers as a wellness benefit. The FDA should facilitate tax write-offs just as they do for other physician-approved medical devices.

Also, most wireless service providers will charge you an extra $10 a month to add a cellular Apple Watch to an existing wireless plan. That strikes me as a bit much considering these things aren't as data-hungry as phones and tablets. A $5 monthly charge seems more reasonable.

Bottom line: Not everyone will have a need for a high-end smartwatch, beyond the novelty factor.

But for people who require ready access to data to manage a medical condition, or who would benefit from knowing they can get help with the push of a button, this device is a game changer.

And it will only get better.

(c)2017 Los Angeles Times

Visit the Los Angeles Times at

Distributed by Tribune Content Agency, LLC.



blog comments powered by Disqus

Social Connections


Rudy Park Ballard Street Clay Bennett Bob Gorrell Lisa Benson Carpe Diem